All Disease X articles
-
NewsScientists identify more effective way to detect poultry viruses in live markets
Scientists have found that viruses circulating in live poultry markets can be detected more effectively by sampling the surrounding environment than by testing individual birds. The study shows that environmental sampling can uncover a broader range of poultry viruses.
-
NewsStudy warns of underrecognized Lassa Fever threat with global implications
A new study shows an urgent need for improved detection and treatment of Lassa fever. The study in Liberia found a high prevalence of Lassa fever among febrile admissions: 11% of patients with fever had Lassa fever despite not being suspected clinically.
-
News Thermo Fisher Scientific launches new color-based culture media to help detect Candida infections faster
Thermo Fisher Scientific today announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar, new color-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species.
-
NewsHuge toll: Bird flu rampant among black vultures
More than four out of every five dead black vultures examined by University of Georgia researchers tested positive for highly pathogenic avian influenza, according to a new study. Their indiscriminate scavenging appears to sustain transmission of the virus beyond the typical bird flu season.
-
NewsTackling tuberculosis systematically: How the environment shapes TB risk
Researchers introduce the concept of the “tuberculogenic environment”: the complex interplay of structures, rules, and living conditions that keep certain communities at high TB risk, even when care is available.
-
NewsImaging technique is step towards needed treatments for hantaviruses in new molecular ma
Researchers have produced a detailed blueprint, the highest resolution yet, for a protein complex the Andes virus uses to infect host cells. The new detailed structural information enabled the researchers to produce a vaccine candidate that caused mice to produce neutralizing antibodies against the Andes virus.
-
NewsYou don’t need to be very altruistic to stop an epidemic
Researchers have used a mathematical model of epidemic behaviour to find that even people who are only barely altruistic - valuing their own life as equivalent to the lives of around 100,000 others – would still see it as rational to drastically reduce their social contacts when infected.
-
NewsPower grids to epidemics: study shows small patterns trigger systemic failures
Why do some systems collapse suddenly after what seems like a minor disturbance? In nature, a local disease outbreak can quickly escalate into an epidemic. New research suggests that in many cases, the key isn’t the entire system – but its smallest building blocks.
-
NewsDebilitating virus can spread in cool weather, increasing health risk in Europe
Chikungunya virus, a debilitating tropical disease caused by infected mosquito bites, poses a greater health threat in Europe than previously thought because it can be spread when air temperatures are as low as 13 degrees Celsius.
-
NewsStrategic changes in water treatment could prevent disease outbreaks
A breakthrough new study shows how strategic changes in water treatment effectively treated a deadly outbreak of Legionnaires’ Disease. For the first time, the study provides evidence of an outbreak being stopped by introducing disinfection to previously untreated groundwater.
-
NewsGlobal commitment on display as countries negotiate key annex to the Pandemic Agreement
Member States of the World Health Organization (WHO) concluded a weeklong round of negotiations on draft annex for Pathogen Access and Benefit Sharing (PABS) – a key component of the WHO Pandemic Agreement.
-
NewsMpox: recombinant virus with genomic elements of clades Ib and IIb
Recombination of monkeypox virus (MPXV) strains has been documented in recent months, with two cases of a recombinant strain comprising clade Ib and IIb MPXV reported, the World Health Organization says.
-
NewsCommunity spread drives ongoing measles transmission in Europe
Preliminary data for 2025 show a significant drop in the number of reported measles cases across EU/EEA countries compared with 2024. However, these figures are still twice as high than those reported in 2023.
-
NewsNew dashboard helps predict and plan for disease outbreaks
When infectious diseases surge, response often comes down to whether communities can position the right people and supplies before case counts spike. Researchers have designed a new platform to translate academic disease forecasting into actionable guidance for decision-makers.
-
NewsSix years after COVID-19’s global alarm: Is the world better prepared for the next pandemic?
Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease. As we cross this six-year mark, WHO asks: Is the world better prepared for the next pandemic?
-
NewsNipah virus outbreak: Risk of global threat is low, say experts
The Global Virus Network is monitoring reports of a Nipah virus outbreak in India and emphasizes that such cases, while very concerning and serious, are not unexpected or unprecedented.
-
NewsScientists say these two viruses may become the next public health threats
Two emerging pathogens with animal origins — influenza D virus and canine coronavirus — have so far been quietly flying under the radar, but researchers warn conditions are ripe for the viruses to spread more widely among humans.
-
NewsIn rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.
A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to one kind of Chikungunya vaccine, which is no longer available in the U.S.
-
NewsNew platform could develop vaccines faster than ever before
Scientists are optimizing a vaccine-development platform created to accelerate how quickly life-saving vaccines can be designed and deployed during infectious-disease outbreaks such as the COVID-19 pandemic.
-
NewsPreparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces a stable and functional immune response in humans that persists for at least two years after a booster vaccination.